Discovery reveals main cause of inflammatory bowel disease

WEB DESK: Scientists uncovered a key factor behind inflammatory bowel disease (IBD), a condition affecting around 5 per cent of the global population.

This breakthrough is described as a “massive step forward” by experts as it offers new insights into the disease’s origins and potential treatments.

Read more: Breaking the silence: Exploring the “Mental Health Awareness Month”

Researchers identified a specific part of a human deoxyribonucleic acid (DNA), active in certain immune cells and that plays a critical role in driving inflammation within the intestines. The genetic anomaly was found in 95 per cent of people with the disease. It allows immune cells known as macrophages to overproduce inflammatory proteins, contributing to the chronic inflammation seen in IBD.

The identification of the genetic pathway represents a significant advancement in current understanding and knowledge of the inflammatory bowel disease. It also opens the door to the development of targeted treatments, with existing drugs showing promise in reversing the disease’s progression in laboratory experiments.

However, translating these findings into effective therapies for patients will require careful calibration of medications to mitigate potential side effects. The ultimate goal is to suppress bowel inflammation without compromising the body’s ability to combat infections.

Read more: Health experts caution against these foods right after Ramazan

While clinical trials are still in the planning stages, this research offers hope for the future management of IBD. By unraveling the underlying mechanisms driving the disease, scientists are paving the way for more effective treatments and, ultimately, improved outcomes for patients.